Allison SchulkinsChief Operating Officer at Single Cell TechnologySpeaker
Profile
Allison Schulkins is the COO at Single Cell Technology. She has been leading improvements in cell isolation, antibody screening, and sequence amplification techniques to transform the AbTheneum platform into a powerful pipeline. She harmonizes the engineering and biology aspects of the platform and works with clients to apply AbTheneum technology to their drug discovery challenges. She has a B.S. in Biochemistry from University of California, Santa Barbara and an M.S. in Chemical Engineering from San Jose State University.
Allison Schulkins's Network
Agenda Sessions
Breaking Barriers in Antibody Discovery with Innovative Cell Isolation
, 1:45pmView Session